| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |